Cranial Electrotherapy Stimulation: Piloting a Road to PTSD Prevention in First Responders
1 other identifier
interventional
13
1 country
1
Brief Summary
The goal of this study is to test whether active duty firefighters find it possible and suitable to do cranial electrotherapy stimulation (CES) at home, and test whether CES influences measures of depression and posttraumatic stress. The main questions it aims to answer are:
- is CES feasible and acceptable in a population of firefighters, and
- does CES changes feelings of depression, anxiety, and fatigue in firefighters. Participants will
- complete four weeks of CES at home, and
- complete daily assessments of affect and fatigue, and
- complete self-reported symptoms of depression and posttraumatic stress before and after four weeks of CES at home Participants maybe asked to
- complete an MRI scan before and after four weeks of CES at, and
- wear a device to measure their heart rate and sleep quality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 8, 2023
CompletedFirst Posted
Study publicly available on registry
January 12, 2024
CompletedStudy Start
First participant enrolled
April 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 3, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 3, 2025
CompletedResults Posted
Study results publicly available
November 5, 2025
CompletedNovember 5, 2025
October 1, 2025
1.1 years
November 8, 2023
October 14, 2025
October 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Feasibility of Cranial Electrotherapy Stimulation
Feasibility assessed by number of completed cranial electrotherapy stimulation sessions over the course of four weeks (feasible is defined as more than 75% of sessions completed).
During four weeks of cranial electrotherapy stimulation at-home use
Acceptability of Cranial Electrotherapy Stimulation
Acceptability assessed by number of individuals who complete at least 75% of all cranial electrotherapy stimulation sessions during four weeks
During four weeks of cranial electrotherapy stimulation
Secondary Outcomes (4)
Severity of Symptoms of Posttraumatic Stress Disorder as Measured With the PTSD Checklist for DMS 5 (PCL-5)
Post four weeks of cranial electrotherapy stimulation
Severity of Symptoms of Depression as Measured With the Inventory of Depressive Symptomatology-Self Report (IDS-SR)
post four weeks of cranial electrotherapy stimulation.
Intensity of Feelings of Fatigue
Daily throughout four weeks of cranial electrotherapy stimulation
Intensity of Feelings of Anxiety
Daily throughout four weeks of cranial electrotherapy stimulation
Study Arms (1)
Alpha-Stim AID cranial electrotherapy stimulation
EXPERIMENTALFour-week course of noninvasive cranial electrotherapy stimulation.
Interventions
Cranial electrotherapy stimulation using a modified square, bipolar waveform of 0.5 Hz at 100 μA to be used for four weeks on off-duty days.
Eligibility Criteria
You may qualify if:
- Active duty firefighter in Rhode Island, USA;
- Age between 18 and 56 years old;
- Be in good medical health or, if having chronic medical conditions, these conditions needed to be stable;
- Ability to speak, read, write, and understand English sufficiently well to complete study procedures and provide informed consent.
You may not qualify if:
- MRI and CES-related contraindications, e.g., implanted metallic device or substances including pacemakers, cochlear implant, metallic tattoos, claustrophobia, pregnancy or planning to become pregnant during the study duration and nursing;
- Neurological conditions such as brain neoplasm, cerebrovascular events, epilepsy or history of seizures, dementia, and neurodegenerative disorders, or had previously received brain surgery;
- Report presence of suicidal ideation on QuickSCID-5 or has attempted suicide one or more times within the past twelve months;
- Exhibiting a psychiatric condition that would require inpatient or partial psychiatric hospitalization;
- Current moderate or severe alcohol or other substance abuse (excluding nicotine);
- Major or unstable medical illness requiring further investigation or treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Butler Hospitallead
- University of Rhode Islandcollaborator
- Brown Universitycollaborator
Study Sites (1)
Butler Hospital
Providence, Rhode Island, 02906, United States
Results Point of Contact
- Title
- Mascha van 't Wout-Frank
- Organization
- Butler Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Mascha van 't Wout-Frank, PhD
Butler Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 8, 2023
First Posted
January 12, 2024
Study Start
April 29, 2024
Primary Completion
June 3, 2025
Study Completion
June 3, 2025
Last Updated
November 5, 2025
Results First Posted
November 5, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share